Clinical Research Directory
Browse clinical research sites, groups, and studies.
Myopia Control With a Innovative Spectacle Lens - A Cessation Study
Sponsor: Essilor International
Summary
The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.
Official title: Clinical Evaluation of A Innovative Spectacle Lens in Slowing Myopia Progression - A Cessation Study
Key Details
Gender
All
Age Range
9 Years - 15 Years
Study Type
INTERVENTIONAL
Enrollment
91
Start Date
2025-02-18
Completion Date
2026-11
Last Updated
2026-09-11
Healthy Volunteers
Yes
Conditions
Interventions
Single Vision Lens to A innovative spectacle lens
Participants in this arm are from the test group of the previous clinical trial (NCT05174780), where they wore the innovative spectacle lenses for three years. They will now wear single vision lenses for 12 months.
Single Vision Lens to A innovative spectacle lens
Participants in this arm are from the control group of the previous clinical trial (NCT05174780), where they wore the single vision spectacle lenses for three years. They will now wear single vision lenses for another 12 months.
Locations (5)
Illinois College of Optometry
Chicago, Illinois, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
New England College of Optometry
Boston, Massachusetts, United States
SUNY College of Optometry
New York, New York, United States
Sacco Eye Group
Vestal, New York, United States